Education
About Us
Working with TipRanks
Follow Us
Sera Prognostics (SERA)
NASDAQ:SERA
Earnings Data
Report Date
May 13, 2026After Close (Confirmed)
Period Ending
2026 (Q1)Consensus EPS Forecast
-0.17Last Year’s EPS
-0.2Same Quarter Last Year
Moderate Buy
Based on 2 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The call conveyed strong clinical and strategic progress anchored by PRIME publication (demonstrating large reductions in extreme preterm birth and NICU use), expanded state/payer engagement, leadership hires, and a healthy cash runway through 2028. However, commercial revenue remains extremely modest and volatile (Q4 revenue down ~58%), the company is still unprofitable, and broader payer coverage and real-world adoption are required to convert clinical success into meaningful revenue. On balance, the material clinical evidence, growing partner programs, and multi-year cash runway materially de-risk near-term funding and enable commercialization efforts, outweighing the current low revenue base and execution risks.Company Guidance
PRIME Pivotal Study Published with Strong Clinical Outcomes
PRIME was accepted for publication (published January 2026) and presented at SMFM; reported 56% fewer babies born before 32 weeks and 32% fewer babies born before 35 weeks versus control, reinforcing RCT-level evidence that biomarker-based identification plus a preventive pathway can reduce preterm birth.
Reduction in Neonatal Utilization
Post-PRIME data cited a 20% reduction in NICU admissions, supporting potential health economic benefits and a major driver for payer and state interest in adoption.
Expanded State and Payer Engagement
Exceeded 2025 goals: active discussions expanded to 13 states (vs goal of 6) and 10 payers; two live partner programs launched. Targeting 15–17 states (58%–60% of U.S. births) and 5–7 partner programs by end of 2026 to drive coverage and utilization.
Strategic Commercial and Clinical Leadership Hires
Strengthened leadership team with a new Chief Commercial Officer (Lee Anderson), Chief Medical Officer (Dr. Tiffany Inglis), and Head of Sales & Strategic Accounts (Adrian Lugo) to support commercialization and payer engagement.
European Regulatory Progress
Advancing PreTRM Global regulatory pathway toward CE marking with dossiers expected to be submitted in the coming months; European expert commentary aligns PRIME approach with regional care models, supporting international expansion plans.
Disciplined Expense Management and Improved Losses
Q4 operating expenses down to $9.0M from $9.4M prior year (≈-4.3%). Full-year net loss narrowed to $31.9M from $32.9M in 2024 (≈-3.0%), reflecting reallocation from R&D toward commercial readiness.
Strong Cash Position and Multi-Year Runway
Ended FY2025 with $95.8M in cash, equivalents, and AFS securities and management guidance that current capital supports operations and commercialization milestones through 2028; ATM facility reestablished to preserve optionality.
SERA Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
SERA Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Mar 18, 2026 | $1.91 | $1.79 | -6.28% |
Nov 13, 2025 | $2.95 | $2.96 | +0.34% |
Aug 06, 2025 | $2.75 | $2.60 | -5.45% |
May 07, 2025 | $2.40 | $2.12 | -11.67% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Sera Prognostics (SERA) report earnings?
Sera Prognostics (SERA) is schdueled to report earning on May 13, 2026, After Close (Confirmed).
What is Sera Prognostics (SERA) earnings time?
Sera Prognostics (SERA) earnings time is at May 13, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is SERA EPS forecast?
SERA EPS forecast for the fiscal quarter 2026 (Q1) is -0.17.